Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis

Biomaterials

Volumn 35, Issue 1, 2014, Pages 538-549

  Bajpayee, Ambika G ^a   Wong, Cliff R ^b   Bawendi, Moungi G ^b   Frank, Eliot H ^b   Grodzinsky, Alan J ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Avidin; Cartilage; Charge; Drug delivery; Post traumatic osteoarthritis; Size

Indexed keywords

AVIDIN; CHARGE; EXTRACELLULAR MATRICES; HYDRODYNAMIC DIAMETER; NEGATIVE FIXED CHARGE; POSITIVELY CHARGED PROTEINS; POST-TRAUMATIC OSTEOARTHRITIS; SIZE;

BINDING SITES; DRUG DELIVERY; ELECTROSTATICS; GLYCOPROTEINS;

CARTILAGE;

AVIDIN; NANOCARRIER;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CARTILAGE; CARTILAGE MATRIX; COW; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HYDRODYNAMICS; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; SOLUTE; STATIC ELECTRICITY;

AVIDIN; CARTILAGE; CHARGE; DRUG DELIVERY; POST-TRAUMATIC OSTEOARTHRITIS; SIZE;

ANIMALS; AVIDIN; CARTILAGE, ARTICULAR; CATTLE; DRUG DELIVERY SYSTEMS; GLYCOSAMINOGLYCANS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; OSTEOARTHRITIS; SURFACE PROPERTIES; WOUNDS AND INJURIES;

EID: 84887015497     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.091     Document Type: Article

References (54)

1. Le Graverand-Gastineau M.-P.H. Disease modifying osteoarthritis drugs: facing development challenges and choosing molecular targets. Curr Drug Targets 2010, 5:528-535.
2. Felson D.T., Neogi T. Osteoarthritis: is it a disease of cartilage or of bone?. Arthritis Rheum 2004, 50(2):341-344.
3. Wieland H.A., Michaelis M., Kirschbaum B.J., Rudolphi K.A. Osteoarthritis-an untreatable disease?. Nat Rev Drug Discov 2005, 4(4):331-344.
4. Bay-Jensen A.-C., Hoegh-Madsen S., Dam E., Henriksen K., Sondergaard B.C., Pastoureau P., et al. Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?. Rheumatol Int 2010, 30(4):435-442.
5. Brown T.D., Johnston R.C., Saltzman C.L., Marsh J.L., Buckwalter J.A. Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. JOrthop Trauma 2006, 20(10):739-744.
6. Anderson D.D., Chubinskaya S., Guilak F., Martin J.A., Oegema T.R., Olson S.A., et al. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. JOrthop Res Off Publ Orthop Res Soc 2011 Jun, 29(6):802-809.
7. Lohmander L.S., Englund P.M., Dahl L.L., Roos E.M. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. Am J Sports Med 2007, 35(10):1756-1769.
8. Irie K., Uchiyama E., Iwaso H. Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee 2003 Mar, 10(1):93-96.
9. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.-P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2010 Nov 30, 7(1):33-42.
10. Aaltonen K.J., Virkki L.M., Malmivaara A., Konttinen Y.T., Nordström D.C., Blom M. Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis. PLoS ONE 2012, 7(1):e30275.
11. Hunter D.J. Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat Rev Rheumatol 2011, 7(1):13-22.
12. Matthews G.L., Hunter D.J. Emerging drugs for osteoarthritis. Expert Opin Emerg Drugs 2011, 16(3):479-491.
13. Lu Y.C., Evans C.H., Grodzinsky A.J. Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines. Arthritis Res Ther 2011, 13(5):R142.
14. Nixon A.J., Brower-Toland B.D., Bent S.J., Saxer R.A., Wilke M.J., Robbins P.D., et al. Insulinlike growth factor-I gene therapy applications for cartilage repair. Clin Orthop Relat Res 2000, (Suppl.379):S201-S213.
15. Miller R.E., Grodzinsky A.J., Cummings K., Plaas A.H.K., Cole A.A., Lee R.T., et al. Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate. Arthritis Rheum 2010, 62(12):3686-3694.
16. Gerwin N., Hops C., Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev 2006, 58(2):226-242.
17. Gardner C.R. Potential and limitations of drug targeting: an overview. Biomaterials 1985, 6(3):153-160.
18. Rothenfluh D.A., Bermudez H., O'Neil C.P., Hubbell J.A. Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat Mater 2008, 7(3):248-254.
19. Butoescu N., Seemayer C.A., Foti M., Jordan O., Doelker E. Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials 2009, 30(9):1772-1780.
20. Horisawa E., Kubota K., Tuboi I., Sato K., Yamamoto H., Takeuchi H., et al. Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharm Res 2002, 19(2):132-139.
21. Tunçay M., Caliş S., Kaş H.S., Ercan M.T., Peksoy I., Hincal A.A. Invitro and invivo evaluation of diclofenac sodium loaded albumin microspheres. JMicroencapsul 2000, 17(2):145-155.
22. Vemula P.K., Boilard E., Syed A., Campbell N.R., Muluneh M., Weitz D.A., et al. On-demand drug delivery from self-assembled nanofibrous gels: a new approach for treatment of proteolytic disease. JBiomed Mater Res A 2011, 97(2):103-110.
23. Burt H.M., Tsallas A., Gilchrist S., Liang L.S. Intra-articular drug delivery systems: overcoming the shortcomings of joint disease therapy. Expert Opin Drug Deliv 2009, 6(1):17-26.
24. Elsaid K.A., Ferreira L., Truong T., Liang A., Machan J., D'Souza G.G. Pharmaceutical nanocarrier association with chondrocytes and cartilage explants: influence of surface modification and extracellular matrix depletion. Osteoarthr Cartil 2013, 21(2):377-384.
25. Comper W.D. Cartilage: molecular aspects 1991, 59-96. CRC Press, Boston. B.K. Hall, S.A. Newman (Eds.).
26. Ng L., Grodzinsky A.J., Patwari P., Sandy J., Plaas A., Ortiz C. Individual cartilage aggrecan macromolecules and their constituent glycosaminoglycans visualized via atomic force microscopy. JStruct Biol 2003, 143(3):242-257.
27. Maroudas A. Transport of solutes through cartilage: permeability to large molecules. JAnat 1976, 122(Pt 2):335-347.
28. Snowden J.M., Maroudas A. The distribution of serum albumin in human normal and degenerate articular cartilage. Biochim Biophys Acta 1976, 428(3):726-740.
29. Byun S., Sinskey Y.L., Lu Y.C.S., Ort T., Kavalkovich K., Sivakumar P., et al. Transport of anti-IL-6 antigen binding fragments into cartilage and the effects of injury. Arch Biochem Biophys 2013, 532(1):15-22.
30. Garcia A.M., Szasz N., Trippel S.B., Morales T.I., Grodzinsky A.J., Frank E.H. Transport and binding of insulin-like growth factor I through articular cartilage. Arch Biochem Biophys 2003, 415(1):69-79.
31. Yao Z., Zhang M., Sakahara H., Saga T., Arano Y., Konishi J. Avidin targeting of intraperitoneal tumor xenografts. JNatl Cancer Inst 1998, 90(1):25-29.
32. Patwari P., Cook M.N., DiMicco M.A., Blake S.M., James I.E., Kumar S., et al. Proteoglycan degradation after injurious compression of bovine and human articular cartilage invitro: interaction with exogenous cytokines. Arthritis Rheum 2003, 48(5):1292-1301.
33. Liu W., Greytak A.B., Lee J., Wong C.R., Park J., Marshall L.F., et al. Compact biocompatible quantum dots via RAFT-mediated synthesis of imidazole-based random copolymer ligand. JAm Chem Soc 2010, 132(2):472-483.
34. Wong C., Stylianopoulos T., Cui J., Martin J., Chauhan V.P., Jiang W., et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. PNAS 2011, 108(6):2426-2431.
35. Liotta L.A., Abe S., Robey P.G., Martin G.R. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci U S A 1979, 76(5):2268-2272.
36. Farndale R.W., Buttle D.J., Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 883(2):173-177.
37. Lotz M.K. New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options. Arthritis Res Ther 2010, 12(3):211.
38. Bendele A.M. Animal models of osteoarthritis. JMusculoskelet Neuronal Interact 2001, 1(4):363-376.
39. Bonassar L.J., Frank E.H., Murray J.C., Paguio C.G., Moore V.L., Lark M.W., et al. Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum 1995, 38(2):173-183.
40. Adam C., Eckstein F., Milz S., Putz R. The distribution of cartilage thickness within the joints of the lower limb of elderly individuals. JAnat 1998, 193(Pt2):203-214.
41. Huffman K.M., Bowers J.R., Dailiana Z., Huebner J.L., Urbaniak J.R., Kraus V.B. Synovial fluid metabolites in osteonecrosis. Rheumatology (Oxford) 2007, 46(3):523-528.
42. Crank J. The mathematics of diffusion 1975, Clarendon Press, Oxford, [Eng].
43. Johnson D.L., Urban W.P., Caborn D.N., Vanarthos W.J., Carlson C.S. Articular cartilage changes seen with magnetic resonance imaging-detected bone bruises associated with acute anterior cruciate ligament rupture. Am J Sports Med 1998, 26(3):409-414.
44. Sui Y., Lee J.H., DiMicco M.A., Vanderploeg E.J., Blake S.M., Hung H.-H., et al. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor α in immature bovine and adult human articular cartilage. Arthritis Rheum 2009, 60(10):2985-2996.
45. Goldberg M., Langer R., Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. JBiomater Sci Polym Ed 2007, 18(3):241-268.
46. Wang W., Li B., Li Y., Jiang Y., Ouyang H., Gao C. Invivo restoration of full-thickness cartilage defects by poly(lactide-co-glycolide) sponges filled with fibrin gel, bone marrow mesenchymal stem cells and DNA complexes. Biomaterials 2010, 31(23):5953-5965.
47. Leddy H.A., Awad H.A., Guilak F. Molecular diffusion in tissue-engineered cartilage constructs: effects of scaffold material, time, and culture conditions. JBiomed Mater Res Part B: Appl Biomater 2004, 70B(2):397-406.
48. Greene G.W., Zappone B., Zhao B., Söderman O., Topgaard D., Rata G., et al. Changes in pore morphology and fluid transport in compressed articular cartilage and the implications for joint lubrication. Biomaterials 2008, 29(33):4455-4462.
49. Torzilli P.A., Arduino J.M., Gregory J.D., Bansal M. Effect of proteoglycan removal on solute mobility in articular cartilage. JBiomech 1997, 30(9):895-902.
50. Torzilli P.A., Grande D.A., Arduino J.M. Diffusive properties of immature articular cartilage. JBiomed Mater Res 1998, 40(1):132-138.
51. Byun S., Tortorella M.D., Malfait A.-M., Fok K., Frank E.H., Grodzinsky A.J. Transport and equilibrium uptake of a peptide inhibitor of PACE4 into articular cartilage is dominated by electrostatic interactions. Arch Biochem Biophys 2010, 499(1-2):32-39.
52. Grodzinsky A.J. Fields, forces, and flows in biological systems 2011, Garland Science, New York, 155-6.
53. Dougherty S.A., Zhang D., Liang J. Fabrication of protein nanotubes using template-assisted electrostatic layer-by-layer methods. Langmuir 2009, 25(22):13232-13237.
54. Moeini M., Quinn T.M. Solute adsorption to surfaces of articular cartilage explants: apparent versus actual partition coefficients. Soft Matter 2012, 8(47):11880-11888.